Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Toshiba Corporation
  6. News
  7. Summary
    6502   JP3592200004

TOSHIBA CORPORATION

(6502)
  Report
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Toshiba : and Midtown Clinic Have Signed a Joint Research Agreement on microRNA Detection Technology for Early Detection of Cancer

03/16/2021 | 10:59pm EDT

TOKYO─ Toshiba Corporation (TOKYO: 6502) has executed a joint research agreement with Midtown Clinic Medical Corporation (hereinafter 'Midtown Clinic') and HIMEIDIC Inc. that will verify the effectiveness of microRNA technology in the early detection of cancer. Midtown Clinic is a Tokyo-based medical center that provides medical services with management support from HIMEDIC Inc., a group company of Resorttrust, Inc. (TOKYO: 4681), the operator of membership-based healthcare and resort businesses.

Toshiba's original miRNA detection technology was developed as part of a Japan Agency for Medical Research and Development (AMED) project, 'Development of Diagnostic Technology for Detection of miRNA in Body Fluids*2,' that promoted key

technologies and the discovery and manufacture of drugs for next-generation cancer diagnosis and treatment.

After further research and development that combined Toshiba's technology and the advanced medical knowledge of Professor Takahiro Ochiya of the Department of Molecular and Cellular Medicine at the Institute of Medical Science, Tokyo Medical University and the National Cancer Center Japan, Toshiba announced the microRNA system on November 25, 2019. At the R&D level the system was found to be able to detect the presence of any of 13 different cancers, including pancreatic cancer and breast cancer, in only a few hours with 99% accuracy. In real-world application, it is expected to detect very early-stage cancers, including stage 0 cancers, and to realize same-day results by using Toshiba's microRNA chip and compact, dedicated testing devices to reduce testing times.

The joint research between Toshiba and Midtown Clinic aims to verify the effectiveness of microRNA detection technology for cancer screening by collecting approximately 1,000 samples and by leveraging the technologies and knowledge of both partners.

Under 'Toshiba Next Plan', five-year transformation plan, Toshiba Group aims to implement cutting-edge technologies that can contribute to society as new infrastructure services. The joint research will be the first step toward the social implementation of miRNA detection technology, which is expected to realize high-precision early detection of cancer.

About Midtown Clinic Medical Corporation

https://www.mtc-nihonbashi.jp/en/clinic/corporate_info/

About HIMEDIC, Inc.

https://www.himedic.co.jp/ (only in Japanese)

https://www.himedic.jp/ (only in Japanese)

*1 microRNA

microRNA molecules, short nucleic acid molecules (consisting of about 20 bases) that regulate genes and proteins in the body, are known to be stable in blood. Examination of the types and quantity of microRNA in blood has recently been found to potentially enable early detection of various cancers, such as lung cancer and breast cancer. This discovery has triggered anticipation for microRNA as a novel diagnostic marker.

*2 'Development of Diagnostic Technology for Detection of miRNA in Body Fluids' project

A project conducted by the National Cancer Research Center in 2014-2018, that aimed to develop a new microRNA-based cancer detection system through comprehensive analysis of miRNA in patients' body fluids.

Disclaimer

Toshiba Corporation published this content on 16 March 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 17 March 2021 03:59:07 UTC.


© Publicnow 2021
All news about TOSHIBA CORPORATION
01:43aTOSHIBA  : QUOTES-Reactions to Toshiba shareholders voting out board chairman
RE
01:42aShareholders oust Toshiba board chairman in big win for Japan governance
RE
01:13aTOSHIBA  : Japan's Toshiba chairman fails to win shareholder approval
AQ
12:29aTOSHIBA  : investor 3D Investment welcomes board changes
RE
12:18aURGENT : Toshiba shareholders reject reappointment of two directors
AQ
06/24TOSHIBA  : board chairman fails to win reappointment in pivotal shareholder vote
RE
06/24Toshiba shareholders vote out board chairman nagayama
RE
06/24Toshiba Corp. Withholding Former CEO's Performance-Based Pay
DJ
06/24TOSHIBA  : investigators defend report, say Japan official stonewalled
RE
06/24TOSHIBA  : New Device Structure Improves SiC MOSFET High Temperature Reliability..
AQ
More news
Financials
Sales 2021 3 076 B 27 746 M 27 746 M
Net income 2021 84 063 M 758 M 758 M
Net Debt 2021 70 157 M 633 M 633 M
P/E ratio 2021 26,0x
Yield 2021 1,01%
Capitalization 2 199 B 19 835 M 19 834 M
EV / Sales 2021 0,74x
EV / Sales 2022 0,70x
Nbr of Employees 125 648
Free-Float 93,4%
Chart TOSHIBA CORPORATION
Duration : Period :
Toshiba Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TOSHIBA CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 10
Last Close Price 4 845,00 JPY
Average target price 4 753,50 JPY
Spread / Average Target -1,89%
EPS Revisions
Managers and Directors
NameTitle
Masayoshi Hirata Chief Financial Officer & Head-Accounting
Satoshi Tsunakawa President & Chief Executive Officer
Keiichi Yumita Head-Information Systems
Yutaka Sata Vice President-Research & Development
Yoshimitsu Kobayashi Independent Outside Director
Sector and Competitors
1st jan.Capitalization (M$)
TOSHIBA CORPORATION67.94%19 835
BERKSHIRE HATHAWAY INC.19.32%628 395
HONEYWELL INTERNATIONAL INC.2.35%151 198
SIEMENS AG15.08%128 911
GENERAL ELECTRIC COMPANY21.76%113 683
3M COMPANY10.57%111 506